Back to results
US 2001/0027194 A1Published application
Novel compounds useful as neuro-protective agents
AssigneeEli Lilly and Company
InventorsBENJAMIN ALAN ANDERSON, LAWRENCE JOSEPH HEINZ, JILL ANN PANETTA, MICHAEL LEROY PHILLIPS, JOHN ALLAN RIECK III, JOHN ROBERT RIZZO, JOHN KEVIN SHADLE, DAVID LEE VARIE
Life of this patent
Estimating the term…
Abstract
This invention relates to novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents.
Claims21
A process of preparing a compound of the formula IV 76
- wherein:
- R1 and R2 are each individually —(C1-C6)alkyl, —(C1-C6)alkoxy or phenyl,
- R3 is H or —(C1-C6)alkyl,
- R6 is —NR7R8, morpholin-1-yl, imidazol-1-yl, 4,5-dihydro-1 H-imidazol-2-yl, thiomorpholin-1-yl, piperazin-1-yl or piperazin-1-yl substituted with —(C1-C4 )alkyl or 77
- and R7 and R8 are each individually hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 78
- —(CH2)p-piperidyl, —(CH2)pS(C1-C6)alkyl, —(CH2)pO(C1-C6)alkyl 79
- where R9 is (C1-C6)alkyl;
- q is 0 or 1;
- and
- t is 1 to 6 both inclusive;
- or a pharmaceutically acceptable salt, hydrate or optical isomer thereof comprising the steps of reacting a compound of the formula X 80
- with an activating agent followed by treatment with a base to form a compound of the formula IX 81
- cyclizing a compound of formula IX to form a compound of formula VIII 82
- Reducing a compound of formula VIII to form a compound of formula VII;
- 83
- mesylating or tosylating a compound of formula VII to form a compound of formula VI where PG is a mesylate or tosylate;
- 84
- alkylating a compound of formula VI with a compound of the formula V 85
- where R7 and R8 are as defined above to form a compound of formula IV.
16 more elements
The process of preparing compound of formula IV (IV) 86
- wherein:
- R1 and R2 are each individually —(C1-C6)alkyl, —(C1-C6)alkoxy or phenyl,
- R3 is H or —(C1-C6)alkyl,
- R6 is —NR7R8, morpholin-1-yl, imidazol-1-yl, 4,5-dihydro-1 H-imidazol-2-yl, thiomorpholin-1-yl, piperazin-1-yl or piperazin-1-yl substituted with —(C1-C4)alkyl or 87
- and R7 and R8 are each individually hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 88
- —(CH2)p-piperidyl, —(CH2)pS(C1-C6)alkyl, —(CH2)pO(C1-C6)alkyl 89
- where R9 is (C1-C6)alkyl;
- q is 0 or 1;
- and
- t is 1 to 6 both inclusive;
- or a pharmaceutically acceptable salt, hydrate or optical isomer thereof which comprises the steps of alkylating a compound of the formula IV 90
- where R1, R2 and q are as defined above;
- with a compound of formula V 91
- where R6 and t are as defined above.
11 more elements
The process of preparing a compound of the formula XX 92
- wherein
- R1 and R2 are each individually —(C1-C6)alkyl, —(C1-C6)alkoxy or phenyl,
- R3 is H or —(C1-C6)alkyl,
- R6 is —NR7R8, morpholin-1-yl, imidazol-1-yl, 4,5-dihydro-1 H-imidazol-2-yl, thiomorpholin-1-yl, piperazin-1-yl or piperazin-1-yl substituted with —(C1-C4)alkyl or 93
- and R7 and R8 are each individually hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 94
- —(CH2)p-piperidyl, —(CH2)pS(C1-C6)alkyl, —(CH2)pO(C1-C6)alkyl 95
- where R9 is (C1-C6)alkyl;
- q is 0 or 1;
- and
- t is 1 to 6 both inclusive;
- or a pharmaceutically acceptable salt, hydrate or optical isomer thereof which comprises the steps of reacting a compound of the formula XXVII 96
- with an activating agent followed by coupling with a serine methyl ester of the formula 97
- where R3 is as defined above, to form a compound of the formula XXVI;
- 98
- cyclizing a compound of formula XXVI to form a compound of formula XXV;
- 99
- oxidizing a compound of formula XXV to form a compound of formula XIV;
- 100
- reducing a compound of formula XXIV to form a compound of formula XXIII;
- 101
- halogenating a compound of formula XXIII to form a compound of formula XXII;
- 102
- where X is halo;
- coupling a compound of formula XXII with a compound of the formula 103
- where R30 is —(CO)R6 or —NR40R41, where one of R40 and R41 is hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 104
- —(CH2)p-piperidyl, —(CH2)pS(C1-C6)alkyl, —(CH2)pO(C1-C6)alkyl 105
- and the other is —(CO)C1-C6 alkyl, to form a compound of the formula XXI;
- 106
- reducing a compound of the formula XXI to form a compound of formula XX.
26 more elements
A process of preparing a compound of the formula 107
- wherein
- R1 and R2 are each individually —(C1-C6)alkyl, —(C1-C6)alkoxy or phenyl,
- R3 is H or —(C1-C6)alkyl,
- R6 is —NR7R8, morpholin-1-yl, imidazol-1-yl, 4,5-dihydro-1 H-imidazol-2-yl, thiomorpholin-1-yl, piperazin-1-yl or piperazin-1-yl substituted with —(C1-C4)alkyl or 108
- alkyl);
- and R7 and R8 are each individually hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 109
- —(CH2)p-piperidyl, —(CH2)pS(C1-C6)alkyl, —(CH2)pO(C1-C6)alkyl 110
- where R9 is (C1-C6)alkyl;
- q is 0 or 1;
- and
- t is 1 to 6 both inclusive;
- or a pharmaceutically acceptable salt, hydrate or optical isomer thereof which comprises coupling a compound of formula XXII 111
- where R30 is —(CO)R6 or —NR40R41, where one of R40 and R41 is hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 112
- —(CH2)p-piperidyl, —(CH2)pS(C1-C6)alkyl, —(CH2)pO(C1-C6)alkyl 113
- and the other is —(CO)C1-C6 alkyl, to form a compound of the formula XXI;
- 114
- and reducing a compound of the formula XXI to form a compound of formula XX.
14 more elements
The process of preparing a compound of formula XX 115
- wherein
- R1 and R2 are each individually —(C1-C6)alkyl, —(C1-C6)alkoxy or phenyl,
- R3 is H or —(C1-C6)alkyl,
- R6 is —NR7R8, morpholin-1-yl, imidazol-1-yl, 4,5-dihydro-1 H-imidazol-2-yl, thiomorpholin-1-yl, piperazin-1-yl or piperazin-1-yl substituted with —(C1-C4)alkyl or 116
- and R7 and R8 are each individually hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 117
- —(CH2)p-piperidyl, —(CH2)ps(C1-C6)alkyl, —(CH2)pO(C1-C6)alkyl 118
- where R9 is (C1-C6)alkyl;
- q is 0 or 1;
- and
- t is 1 to 6 both inclusive;
- or a pharmaceutically acceptable salt, hydrate or optical isomer thereof which comprises reducing a compound of formula XXI 119
- where R30 is —(CO)R6 or —NR40R41, where one of R40 and R41 is hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 120
- —(CH2)p-piperidyl, —(CH2)pS(C1-C6)alkyl, 121
- and the other is —(O)C1-C6 alkyl.
11 more elements
A compound of the formula XXI 122
- wherein:
- R1 and R2 are each individually —(C1-C6)alkyl, —(C1-C6)alkoxy or phenyl,
- R3 is H or —(C1-C6)alkyl,
- R30 is —(CO)R6 or —NR40R41, where one of R40 and R41 is hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 123
- —(CH2)p-piperidyl, —(CH2)pS(C1-C6)alkyl, —(CH2)pO(C1-C6)alkyl 124
- and the other is —(CO)C1-C6 alkyl,
- where R6 is —NR7R8, morpholin-1-yl, imidazol-1-yl, 4,5-dihydro-1 H-imidazol-2-yl, thiomorpholin-1-yl, piperazin-1-yl or piperazin-1-yl substituted with —(C1-C4)alkyl or 125
- and R7 and R8 are each individually hydrogen, —(C1-C6)alkyl, —(CH2)pOH, 126
- —(CH2)p-piperidyl, —(CH2)pS(C1-C6)alkyl, —(CH2)pO(C1-C6)alkyl 127
- where R9 is (C1-C6)alkyl;
- q is 0 or 1;
- and
- t is 1 to 6 both inclusive;
- or a pharmaceutically acceptable salt, hydrate or optical isomer thereof.
11 more elements
Dependencies are inferred from the claim text.